Advances in sensing electronics and signal processing are paving the way for glucose monitors that have the potential to eliminate the need for invasive blood sampling. Noninvasive monitors winding their way through the development and clinical trial process include novel optical, RF, and spectroscopy systems. Healthcare providers agree that the ability to monitor glucose levels in a painless and consistent way has the potential to improve the quality of life for millions of diabetes patients. But the challenge of consistently and reliably measuring glucose levels noninvasively is a daunting technical challenge that must take into account the physiological variations and user needs of patients across a broad genetic and socioeconomic spectrum. These monitors must be extremely accurate and reliable, and usable by almost anyone.
Companies active in this sector are as varied as the technology and engineering approaches they pursue, Companies successful in commercializing their products will be those that have the ability to attract and manage financial resources over a protracted product development cycle.
These findings are contained in a new and comprehensive report: Noninvasive Glucose Monitors: Technologies, Devices and Commercialization Potential. The report includes a comprehensive assessment of noninvasive glucose monitoring product candidates, profiles of market participants, technology risk factors, and analysis of regulatory and market factors.
More information is available at greystoneassociates.
About Greystone
Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.
Greystone Associates
Комментариев нет:
Отправить комментарий